Published in Lab Business Week, July 16th, 2006
Study 1: Bifunctional quinolonyl diketo acid derivatives inhibit HIV-1 integrase.
According to recent research published in the Journal of Medicinal Chemistry, "The virally encoded integrase protein is an essential enzyme in the life cycle of the HIV-1 virus and represents an attractive and validated tar get in the development of therapeutics against HIV infection.
"Drugs that selectively inhibit this enzyme, when used in combination with inhibitors of reverse transcriptase and protease, are believed to be highly effective in suppressing the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-07-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.